1.73BMarket Cap-34696P/E (TTM)
22.910High22.430Low162.48KVolume22.430Open22.430Pre Close3.71MTurnover0.64%Turnover RatioLossP/E (Static)75.53MShares25.88052wk High4.13P/B584.54MFloat Cap16.49052wk Low--Dividend TTM25.53MShs Float29.000Historical High--Div YieldTTM2.14%Amplitude12.490Historical Low22.814Avg Price1Lot Size
MeridianLink Stock Forum
Reported strong third-quarter results and continues to benefit from the accelerated digital transformation of financial services. The Company continues to add new quality customers and expand its relationships with existing customers in a wide range of markets, including lenders, financial service providers and information providers. Continue to expand further into adjacent markets and expand its product offering with increasing services and enhanced data validation, including the ability to provide repeated background checks to reduce risk and add new features to its advanced QuickApp tool to enable its customers to better serve their customers
$Elicio Therapeutics (ELTX.US)$ $Candel Therapeutics (CADL.US)$ $Context Therapeutics (CNTX.US)$ $Dole plc (DOLE.US)$ $Duolingo (DUOL.US)$ $MeridianLink (MLNK.US)$ $PowerSchool (PWSC.US)$ $Snap One (SNPO.US)$ $Icosavax (ICVX.US)$ $Preston Hollow Community Capital (PHCC.US)$ $Rallybio (RLYB.US)$ $Riskified (RSKD.US)$
No comment yet